These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19601815)

  • 1. Neuromodulators and therapeutic targets in neuropathic pain: from molecules to man.
    Bermejo PE; Anciones B
    CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):175-83. PubMed ID: 19601815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New antiepileptic drugs and neuropathic pain. From molecular medicine to clinical practice].
    Bermejo Velasco PE; Velasco Calvo R
    Med Clin (Barc); 2007 Oct; 129(14):542-50. PubMed ID: 17983534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain.
    Yogeeswari P; Semwal A; Mishra R; Sriram D
    Expert Opin Ther Targets; 2009 Aug; 13(8):925-43. PubMed ID: 19538098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic receptors and pain.
    Burnstock G
    Curr Pharm Des; 2009; 15(15):1717-35. PubMed ID: 19442186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neuropathic pain: mechanisms, drug targets and measurement.
    Finnerup NB; Sindrup SH; Jensen TS
    Fundam Clin Pharmacol; 2007 Apr; 21(2):129-36. PubMed ID: 17391285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecules targeting sodium and calcium channels for neuropathic pain.
    Bear B; Asgian J; Termin A; Zimmermann N
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):543-61. PubMed ID: 19562650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions in the treatment of neuropathic pain: a review on various therapeutic targets.
    Gangadhar M; Mishra RK; Sriram D; Yogeeswari P
    CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):63-81. PubMed ID: 24152326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic opportunities for targeting cold pain pathways.
    Yin K; Zimmermann K; Vetter I; Lewis RJ
    Biochem Pharmacol; 2015 Jan; 93(2):125-40. PubMed ID: 25316567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sodium channel antagonists in the treatment of neuropathic pain.
    Rivara M; Zuliani V
    Expert Opin Investig Drugs; 2016; 25(2):215-26. PubMed ID: 26576738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain.
    Jaggi AS; Singh N
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):589-609. PubMed ID: 21631400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulators of G protein signalling as pharmacological targets for the treatment of neuropathic pain.
    Doyen PJ; Beckers P; Brook GA; Hermans E
    Pharmacol Res; 2020 Oct; 160():105148. PubMed ID: 32858121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why are antiepileptic drugs used for nonepileptic conditions?
    Bialer M
    Epilepsia; 2012 Dec; 53 Suppl 7():26-33. PubMed ID: 23153207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiology of neuropathic pain: mode of action of anticonvulsants.
    Dickenson AH; Matthews EA; Suzuki R
    Eur J Pain; 2002; 6 Suppl A():51-60. PubMed ID: 11888242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptor signalling: Probing the potential pathways for the ministration of neuropathic pain.
    Shaw S; Uniyal A; Gadepalli A; Tiwari V; Belinskaia DA; Shestakova NN; Venugopala KN; Deb PK; Tiwari V
    Eur J Pharmacol; 2020 Dec; 889():173619. PubMed ID: 33011242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zonisamide and neuropathic pain].
    López-Trigo J; Ortiz-Sánchez P; Blanco-Hernández T
    Rev Neurol; 2007 Oct 1-15; 45(7):429-32. PubMed ID: 17918110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathic pain: mechanisms and treatments.
    Ro LS; Chang KH
    Chang Gung Med J; 2005 Sep; 28(9):597-605. PubMed ID: 16323550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy.
    Islam N; Abbas M; Rahman S
    CNS Neurol Disord Drug Targets; 2017; 16(3):303-310. PubMed ID: 27978796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic drugs in the treatment of neuropathic pain.
    Attal N
    Expert Rev Neurother; 2001 Nov; 1(2):199-206. PubMed ID: 19811032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Growth Factors as Tools in the Management of Neuropathic Pain Disorders.
    Forouzanfar F; Sadeghnia HR
    Curr Drug Targets; 2020; 21(10):1034-1043. PubMed ID: 32324511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.